HAVCR2 and leukemia: A recent review describes the role and the mechanisms involved in galectin-mediated development and the progression of different types of leukemia [98], detailing the Gal-9/TIM-3 interaction on the circulating CD8+ T cells to impair immune system function and providing an ideal environment for the proliferation of leukemic cells.